Twenty‐two novel mutations in the lysosomal α‐glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II
暂无分享,去创建一个
D. V. Leenen | J. Fletcher | R. Wevers | G. Besley | M. Kroos | W. Kleijer | H. Sakuraba | C. Beesley | L. Basel‐Vanagaite | A. T. van der Ploeg | E. Kirk | H. Michelakakis | A. Reuser | M. Hermans | N. Bosshard | D. Leenen
[1] O. Bodamer,et al. L-alanine supplementation in late infantile glycogen storage disease type II. , 2002, Pediatric neurology.
[2] M. Kroos,et al. A rare presentation of childhood pompe disease: cardiac involvement provoked by Epstein-Barr virus infection. , 2002, Pediatrics.
[3] B. Byrne,et al. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). , 2002, Current molecular medicine.
[4] M. Roig,et al. Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease) , 2002, Neuromuscular Disorders.
[5] I. Nonaka,et al. Frequent mutations in Japanese patients with acid maltase deficiency , 2000, Neuromuscular Disorders.
[6] A. Vulto,et al. Recombinant human α-glucosidase from rabbit milk in Pompe patients , 2000, The Lancet.
[7] L. Sandkuijl,et al. Glycogen Storage Disease Type II: Birth Prevalence Agrees with Predicted Genotype Frequency , 2000, Public Health Genomics.
[8] M. Kroos,et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling , 1999, European Journal of Human Genetics.
[9] R. Hirschhorn,et al. Frequency of mutations for glycogen storage disease type II in different populations: the Δ525T and Δexon 18 mutations are not generally “common” in white populations , 1999, Journal of medical genetics.
[10] D. V. Leenen,et al. Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal α‐glucosidase gene , 1998 .
[11] C. Tifft,et al. The African origin of the common mutation in African American patients with glycogen-storage disease type II. , 1998, American journal of human genetics.
[12] D. van Leenen,et al. Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing. , 1997, Biochemical and biophysical research communications.
[13] A. Kahn,et al. Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients. , 1997, Biochemical and biophysical research communications.
[14] M. Menaker,et al. Identification of an E689K substitution as the molecular basis of the human acid α‐glucosidase type 4 allozyme (GAA*4) , 1996, Annals of human genetics.
[15] J. Shieh,et al. Identification of a small deletion in one allele of patients with infantile form of glycogen storage disease type II. , 1996, Biochemical and biophysical research communications.
[16] A. Reuser,et al. Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. , 1995, Journal of medical genetics.
[17] C. Boerkoel,et al. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. , 1995, American journal of human genetics.
[18] B. Oostra,et al. The effect of a single base pair deletion (ΔT525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal α-glucosidase in patients with glycogen storage disease type II , 1994 .
[19] S. Dimauro,et al. Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. , 1994, Human molecular genetics.
[20] A. Reuser,et al. Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. , 1994, Biochemical and biophysical research communications.
[21] S. Brooks,et al. A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII). , 1994, Human molecular genetics.
[22] L. Y. Wang,et al. Point mutation in Pompe disease in Chinese , 1994, Journal of Inherited Metabolic Disease.
[23] B. Oostra,et al. The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II. , 1993, The Biochemical journal.
[24] J. van Beeumen,et al. Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. , 1993, The Journal of biological chemistry.
[25] K. Hirschhorn,et al. Identification of a missense mutation in an adult-onset patient with glycogenosis type II expressing only one allele. , 1991, DNA and cell biology.
[26] C. Warlow,et al. Acid maltase deficiency presenting with a myopathy and exercise induced urinary incontinence in a 68 year old male. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[27] L. Hoefsloot,et al. Characterization of the human lysosomal alpha-glucosidase gene. , 1990, The Biochemical journal.
[28] F. Martiniuk,et al. Identification of the base-pair substitution responsible for a human acid alpha glucosidase allele with lower "affinity" for glycogen (GAA 2) and transient gene expression in deficient cells. , 1990, American journal of human genetics.
[29] F. Martiniuk,et al. Sequence of the cDNA and 5'-flanking region for human acid alpha-glucosidase, detection of an intron in the 5' untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. , 1990, DNA and cell biology.
[30] A. Reuser,et al. Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells , 1988, Journal of Neurology.
[31] L. Hoefsloot,et al. Primary structure and processing of lysosomal alpha‐glucosidase; homology with the intestinal sucrase‐isomaltase complex. , 1988, The EMBO journal.
[32] D. Swallow,et al. Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. , 1987, The Journal of clinical investigation.
[33] A. Pellicer,et al. Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Reuser,et al. Defects in synthesis, phosphorylation, and maturation of acid alpha-glucosidase in glycogenosis type II. , 1985, The Journal of biological chemistry.
[35] W. Hwu,et al. Molecular genetic study of Pompe disease in Chinese patients in Taiwan , 1999, Human mutation.
[36] N. Raben,et al. Novel mutations in African American patients with glycogen storage disease type II , 1999 .
[37] J. Shieh,et al. Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: Evidence for a founder effect , 1998, Human mutation.
[38] J. Smeitink,et al. Glycogen storage disease type II: Genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry , 1998, Human mutation.
[39] M. Yacoub,et al. The identification of five novel mutations in the lysosomal acid a‐(1,4) glucosidase gene from patients with glycogen storage disease type II , 1998 .
[40] N. Raben,et al. Glycogenosis type II: A juvenile‐specific mutation with an unusual splicing pattern and a shared mutation in African Americans , 1997, Human mutation.
[41] A. Reuser,et al. Glycogenosis type II (acid maltase deficiency) , 1995, Muscle & nerve. Supplement.
[42] F. Martiniuk,et al. Mutation at the catalytic site (M519V) in glycogen storage disease type II (Pompe disease) , 1994, Human mutation.
[43] C. V. van Noorden,et al. Synthesis and in situ localization of lysosomal alpha-glucosidase in muscle of an unusual variant of glycogen storage disease type II. , 1993, Ultrastructural pathology.
[44] H. Hers. α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease) , 1963 .